O I have extensive experience in formulation and process development for a broad range of molecules and dosage forms, spanning both traditional and nontraditional types, across multiple routes of administration.O My expertise includes hands-on experience with both small and large molecules.O For large molecules, I have led multiple projects in collaboration with academic and pharmaceutical partners. These projects focused on developing stable liquid and dry powder formulations for biologics, intended for parenteral, pulmonary, and nasal delivery using Freeze-drying (Lyophilization) technology. Key areas of my work include:O mRNA-Lipid Nanoparticles (mRNA-LNPs): I led the development of a library of mRNA-LNPs that are stable against freeze-drying and other stresses, enabling delivery via oral inhalation for lung deposition. I also collaborated with pharmaceutical partners to address storage and administration challenges of mRNA-LNPs.O Subunit Protein Vaccines: I developed dry powder formulations for two subunit protein vaccines, adjuvanted with liposomal or oil-in-water nanoemulsion vaccine adjuvants, for intranasal, pulmonary, or parenteral delivery.O Live-Attenuated Virus Vaccines: I contributed to a dry powder formulation for a live-attenuated virus vaccine, stable at temperatures up to 40ºC and suitable for microneedle patch delivery.O Bacteriophage: I developed a stable dry powder formulation of bacteriophages with desirable aerosol performance which is resistant to shear stress.O Additionally, I have contributed to the development of dry powder formulations for monoclonal antibodies (mAbs) for intranasal and parenteral delivery.O For small molecules, my focus has been on enhancing the oral bioavailability of BCS Class II drugs using nanocarriers, particularly self-emulsifying drug delivery systems (SEDDS). Through this work, I have gained expertise in:O Pre-formulation and physicochemical characterization to guide formulation strategies.O Formulating nanocarriers, including SEDDS, nanoemulsions, and polymeric nanocarriers.O Optimization and characterization of formulations.O Conducting dissolution and release testing under physiologically relevant conditions.O Ex vivo drug transport and uptake testing.O Pharmacokinetic and pharmacodynamic analysis.O Overall, I have extensive experience with parenteral, pulmonary, intranasal, and oral delivery of small and large molecules, along with pharmacokinetic (PK) analysis and freeze-drying process development and characterization.